| ViraEpi3293 | Epstein barr virus (EBV) | Cp | NA | 11095 | 11095 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 9 | 6 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3294 | Epstein barr virus (EBV) | Cp | NA | 11104 | 11104 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 9 | 6 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3314 | Epstein barr virus (EBV) | Cp | NA | 11095 | 11095 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 10 | 4 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3323 | Epstein barr virus (EBV) | Cp | NA | 11238 | 11238 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 10 | 4 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3341 | Epstein barr virus (EBV) | Wp | NA | 14381 | 14381 | Intermediate | 57.14% | B cell samples from healthy individual | B cell from healthy donor no. 8 | 7 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3359 | Epstein barr virus (EBV) | Wp | NA | 14381 | 14381 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 9 | 6 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3360 | Epstein barr virus (EBV) | Wp | NA | 14391 | 14391 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 9 | 6 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3373 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Intermediate | 60% | B cell samples from healthy individual | B cell from healthy donor no. 10 | 5 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3374 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | Intermediate | 60% | B cell samples from healthy individual | B cell from healthy donor no. 10 | 5 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3381 | Epstein barr virus (EBV) | Fp | NA | 62104 | 62104 | Intermediate | 50% | B cell samples from healthy individual | B cell from healthy donor no. 8 | 6 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3399 | Epstein barr virus (EBV) | Fp | NA | 62104 | 62104 | Intermediate | 60% | B cell samples from healthy individual | B cell from healthy donor no. 10 | 5 PCR samples | NA | Bisulfite seq | 10559309 | | ViraEpi3598 | Epstein barr virus (EBV) | Cp | NA | 11171 | 11171 | Intermediate | 50% | Raji cell line | EBV +ve cell line | 8 clones | NA | Bisulphite Seq | 19208682 | | ViraEpi3630 | Epstein barr virus (EBV) | LMP-1 | NA | 76035 | 76035 | Intermediate | 50% | Raji cell line | EBV +ve cell line | 10 clones | NA | Bisulphite Seq | 19208682 | | ViraEpi3634 | Epstein barr virus (EBV) | EBER-1 promoter | NA | 4460 | 4464 | Intermediate | 50% | Raji cell line | EBV +ve cell line | NA | NA | Restriction endonuclease analysis | 8393238 | | ViraEpi3640 | Epstein barr virus (EBV) | EBER-1 promoter | NA | 4871 | 4875 | Intermediate | 50% | Raji cell line | EBV +ve cell line | NA | NA | Restriction endonuclease analysis | 8393238 | | ViraEpi3674 | Epstein barr virus (EBV) | Zp | NA | 103638 | 103638 | Intermediate | 60% | Akata cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3682 | Epstein barr virus (EBV) | Zp | NA | 103802 | 103802 | Intermediate | 60% | Akata cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3685 | Epstein barr virus (EBV) | Zp | NA | 103138 | 103138 | Intermediate | 60% | Namalwa cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3686 | Epstein barr virus (EBV) | Zp | NA | 103181 | 103181 | Intermediate | 60% | Namalwa cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3760 | Epstein barr virus (EBV) | Rp | NA | 106303 | 106303 | Intermediate | 50% | Akata cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3772 | Epstein barr virus (EBV) | Rp | NA | 106655 | 106655 | Intermediate | 50% | Akata cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3777 | Epstein barr virus (EBV) | Rp | NA | 106229 | 106229 | Intermediate | 60% | Namalwa cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3779 | Epstein barr virus (EBV) | Rp | NA | 106276 | 106276 | Intermediate | 60% | Namalwa cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3782 | Epstein barr virus (EBV) | Rp | NA | 106376 | 106376 | Intermediate | 60% | Namalwa cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 | | ViraEpi3785 | Epstein barr virus (EBV) | Rp | NA | 106457 | 106457 | Intermediate | 60% | Namalwa cell line | EBV +ve cell line | 5 PCR samples | Burkitt lymphoma (BL) | Methylation Specific PCR (MSP) | 22458933 |